Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1630

1.

ANALYSIS OF LOCAL IMMUNITY INDICATORS OF THE ORAL CAVITY AND DEGREE OF GINGIVITIS DEPENDING ON MUTATION OF CFTR GENE IN CHILDREN WITH CYSTIC FIBROSIS.

Nazaryan R, Tkachenko M, Kovalenko N, Babai O, Karnaukh O, Gargin V.

Georgian Med News. 2019 Nov;(296):27-31.

PMID:
31889700
2.

[Relationship of Cystic Fibrosis Transmembrane Conductance Regulator Expression with Clinical Features and Prognosis in Patients with Acute Leukemia].

Wang HF, Yang X, Liu XH, Naren DL, Sang LN, Yan TY, Zheng X, Li YR, Zhang NC, Gong YP.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 May;50(3):420-424. Chinese.

PMID:
31631611
3.

Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.

Yibcharoenporn C, Chusuth P, Jakakul C, Rungrotmongkol T, Chavasiri W, Muanprasat C.

J Pharmacol Sci. 2019 Jul;140(3):273-283. doi: 10.1016/j.jphs.2019.07.012. Epub 2019 Jul 31.

4.

Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.

Bell SC, Mainz JG, MacGregor G, Madge S, Macey J, Fridman M, Suthoff ED, Narayanan S, Kinnman N.

BMC Pulm Med. 2019 Aug 13;19(1):146. doi: 10.1186/s12890-019-0887-6.

5.

A novel mutation (-195C>A) in the promoter region of CFTR gene is associated with Chinese Congenital Bilateral Absence of Vas Deferens (CBAVD).

Feng J, Wu X, Zhang Y, Yang X, Ma G, Chen S, Luo S, Zhang Y.

Gene. 2019 Nov 30;719:144007. doi: 10.1016/j.gene.2019.144007. Epub 2019 Jul 26.

PMID:
31357024
6.

CFTR regulates B cell activation and lymphoid follicle development.

Polverino F, Lu B, Quintero JR, Vargas SO, Patel AS, Owen CA, Gerard NP, Gerard C, Cernadas M.

Respir Res. 2019 Jul 1;20(1):133. doi: 10.1186/s12931-019-1103-1.

7.

Domain-interface dynamics of CFTR revealed by stabilizing nanobodies.

Sigoillot M, Overtus M, Grodecka M, Scholl D, Garcia-Pino A, Laeremans T, He L, Pardon E, Hildebrandt E, Urbatsch I, Steyaert J, Riordan JR, Govaerts C.

Nat Commun. 2019 Jun 14;10(1):2636. doi: 10.1038/s41467-019-10714-y.

8.

Deletion of exons 16-17b of CFTR is frequently identified in Korean patients with cystic fibrosis.

Sohn YB, Ko JM, Jang JY, Seong MW, Park SS, Suh DI, Ko JS, Shin CH.

Eur J Med Genet. 2019 Aug;62(8):103681. doi: 10.1016/j.ejmg.2019.103681. Epub 2019 May 25.

PMID:
31136843
9.

Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka.

Indika NLR, Vidanapathirana DM, Dilanthi HW, Kularatnam GAM, Chandrasiri NDPD, Jasinge E.

BMC Med Genet. 2019 May 24;20(1):89. doi: 10.1186/s12881-019-0815-x.

10.

Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other Diseases.

Mention K, Santos L, Harrison PT.

Genes (Basel). 2019 May 21;10(5). pii: E387. doi: 10.3390/genes10050387. Review.

11.

Restoration of F508-del Function by Transcomplementation: The Partners Meet in the Endoplasmic Reticulum.

Bergbower EAS, Sabirzhanova I, Boinot C, Guggino WB, Cebotaru L.

Cell Physiol Biochem. 2019;52(6):1267-1279. doi: 10.33594/000000089.

12.

Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic Reticulum.

Santos JD, Canato S, Carvalho AS, Botelho HM, Aloria K, Amaral MD, Matthiesen R, Falcao AO, Farinha CM.

Cells. 2019 Apr 14;8(4). pii: E353. doi: 10.3390/cells8040353.

13.

Unusual Cystic Fibrosis Transmembrane Conductance Regulator Mutations and Liver Disease: A Case Series and Review of the Literature.

Khan HH, Mew NA, Kaufman SS, Yazigi NA, Fishbein TM, Khan KM.

Transplant Proc. 2019 Apr;51(3):790-793. doi: 10.1016/j.transproceed.2018.11.007. Epub 2019 Jan 7. Review.

PMID:
30979466
14.

Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.

Petrova NV, Kashirskaya NY, Saydaeva DK, Polyakov AV, Adyan TA, Simonova OI, Gorinova YV, Kondratyeva EI, Sherman VD, Novoselova OG, Vasilyeva TA, Marakhonov AV, Macek M Jr, Ginter EK, Zinchenko RA.

BMC Med Genet. 2019 Mar 21;20(1):44. doi: 10.1186/s12881-019-0785-z.

15.

Cell-Selective Regulation of CFTR Gene Expression: Relevance to Gene Editing Therapeutics.

Swahn H, Harris A.

Genes (Basel). 2019 Mar 19;10(3). pii: E235. doi: 10.3390/genes10030235. Review.

16.

Activation of constitutive androstane receptor inhibits intestinal CFTR-mediated chloride transport.

Kittayaruksakul S, Sawasvirojwong S, Noitem R, Pongkorpsakol P, Muanprasat C, Chatsudthipong V.

Biomed Pharmacother. 2019 Mar;111:1249-1259. doi: 10.1016/j.biopha.2019.01.015. Epub 2019 Jan 15.

17.

Mutational analysis of CFTR in the Ecuadorian population using next-generation sequencing.

Ruiz-Cabezas JC, Barros F, Sobrino B, García G, Burgos R, Farhat C, Castro A, Muñoz L, Zambrano AK, Martínez M, Montalván M, Paz-Y-Miño C.

Gene. 2019 May 15;696:28-32. doi: 10.1016/j.gene.2019.02.015. Epub 2019 Feb 11.

PMID:
30763667
18.

Contribution of the eighth transmembrane segment to the function of the CFTR chloride channel pore.

Negoda A, Hogan MS, Cowley EA, Linsdell P.

Cell Mol Life Sci. 2019 Jun;76(12):2411-2423. doi: 10.1007/s00018-019-03043-2. Epub 2019 Feb 13.

PMID:
30758641
19.

Genetic and phenotypic traits of children and adolescents with cystic fibrosis in Southern Brazil.

Rosa KMD, Lima EDS, Machado CC, Rispoli T, Silveira VD, Ongaratto R, Comaru T, Pinto LA.

J Bras Pneumol. 2018 Nov-Dec;44(6):498-504. doi: 10.1590/s1806-37562017000000418. English, Portuguese.

20.

Impairment of CFTR activity in cultured epithelial cells upregulates the expression and activity of LDH resulting in lactic acid hypersecretion.

Valdivieso ÁG, Clauzure M, Massip-Copiz MM, Cancio CE, Asensio CJA, Mori C, Santa-Coloma TA.

Cell Mol Life Sci. 2019 Apr;76(8):1579-1593. doi: 10.1007/s00018-018-3001-y. Epub 2019 Jan 1.

PMID:
30599064

Supplemental Content

Support Center